ACUTAAS Acutaas Chemicals Q3 FY26 results (Oct–Dec 2025) and concall
Acutaas Chemical reported a strong Q3 FY26, with significant revenue and profit growth driven by improved product mix and operational efficiency. The company upgraded its full-year revenue and EBITDA margin guidance, while making progress on new growth verticals like battery chemicals and semiconductors. Despite some capex delays and elevated working capital days, management expressed confidence in its strategic direction and pipeline.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 44.3%, net profit up 148.9% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|
| Revenue | 271 | 304 | 206 | 305 | 391 +44% |
| EBITDA | 67 | 84 | 51 | 97 | 154 +130% |
| Net profit | 45 | 63 | 45 | 73 | 112 +149% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
